As part of our mission to support the development of biomedical discoveries up to clinical proof of concept, EATRIS offers learning solutions targeted to the requirements of different audiences. Benefiting from our large network with key opinion leaders in all areas relevant to translational medicine, we will make sure that the courses offer cutting-edge insights.
We will go beyond simply conveying knowledge as we design courses that support the interaction of the participant and faculty so new knowledge can be actively applied supporting a lasting transfer into working practice.
Find out more about various existing opportunities below or get in touch with us at firstname.lastname@example.org to develop your customised training solutions.
In our open e-learning platform TransMed Academy we host online courses as well as recordings of our webinar series.
ONLINE COURSE: THE LANDSCAPE OF TRANSLATIONAL MEDICINE
For the next generation of translational scientists (PhDs, Postdocs and MDs), we have developed an online course touching upon key aspects of translational research and medicines development. Learn more about target validation, predictive models, biomarkers, clinical trials, IP and European regulations through a variety of learning activities such as reading assignments, videos, quizzes and mindmaps.
The course is self-paced and upon successful completion of the course, a certificate can be obtained. Student investment time for the whole course approximately 10 hours.
- Neuroscience 2020 – With the help of NeurATRIS, French node of EATRIS, the French Club of Glial Cells and the GDR “Microglia and neuroinflammation” offer two mini-symposia on “Innovating therapies for glial cell related diseases” and “The role of microglia in health and disease”.
- Quality and Reproducibility 2019/2020 – Reproducibility is a foundational element of the scientific method, a benchmark upon which the reliability of an experiment can be tested. However, the field is facing alarmingly high irreproducibility rates as illustrated in various industry publications, with reports ranging from 50% to 80% of published results not being reproducible. It has been estimated that in the US alone, $28B in funding is spent on preclinical research that is not reproducible. This estimation does not even consider the impact on delaying translational research and causing high failure rates observed for the development of new treatments. In this context, EATRIS ran a series of webinars from November 2019 to February 2020, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation).
- Neuroimaging 2018/2019 – EATRIS and NeurATRIS have joined forces in organizing a series of webinars on Neuroimaging from November 2018 to May 2019, covering the usage of CEST-MRI, optical imaging, PET, preclinical models and Ultrahigh Field MRI in neurodegenerative diseases and their potential application in translational medicine.
ADVANCE PROGRAMME – FOR FUTURE ATMPS DEVELOPERS
Target audiences: early career biomedical scientists
ADVANCE is a 30-month EU training project, supported by Erasmus Plus with the objective to develop a 3-stage blended learning programme to support early-career biomedical scientists in developing currently missing scientific knowledge, transversal skills and competences to meet the key challenge areas existing in the ATMP development cycle.
The programme develops a series of webinars covering career coaching, as well as ATMPs development; a 15-hour online course; and a 5-day face-to-face workshop.
TMEX WINTERSCHOOL – TRANSLATIONAL MEDICINE EXPLAINED
Target audiences: early career biomedical scientists, patient experts
TMex is a 5-day face-to-face workshop designed for PhD students in the second half of their PhD, early postdocs and other young scientists who are involved in biomedical research and want to learn more about Translational Research and medicines’ development.
As a prerequisite participants will complete the 10 hour online course “The Landscape of Translational Medicine” through Transmed Academy.
The course is offered annually. Information about the November 2021 TMex course can be found here.
Register for our online course on ATMP Development pipeline. Currently, the course is hosted by our project partners Elevate Health, and you will need to register on their e-learning platform to start the course. It’s completely free of charge and self-paced!
Target audiences: senior scientists, patient experts, SME based professionals
EATRIS-Plus is our flagship project kicked off in 2020 that aims to build further capabilities and deliver innovative scientific tools to support the long-term sustainability of EATRIS as Europe’s key research infrastructure for Personalised Medicine.
Within Work Package 7 there will be a number of training activities organised between 2021-2023.
5-day Summer School on Translational Medicine that focusses on more advanced aspects of translational medicine, and how translational research can be used for PM applications (for senior academics, healthcare providers and SME based professionals)
2-day Workshop on Best Practices in Public-Private Collaboration – focus on all relevant aspects of setting up such collaborations, from initial contacts through planning and negotiation to completion of legal agreements and project implementation. The workshop will serve as an opportunity to provide hands-on knowledge on how to initiate public-private collaboration in biomedical research and address key issues such as intellectual property strategy (for senior academics, healthcare providers and SME based professionals).
We also aim to expand the current offering of online courses through our learning environment TransMed Academy (see above for access). For example two introductory modules will be co-designed with European Patients Forum, that will deliver content which is currently not offered by existing learning programmes for patient experts, e.g. an introduction to the basic notions of translational medicine, and patient stratification strategies for PM.
Furthermore we will also offer an advanced e-learning module on the use of multi-omic technologies for PM research.
In addition to the F2F and online course offerings two series of webinars will be organised every year to stir interest in the Transmed Academy’s learning offering and to showcase EATRIS’ expertise and capabilities. Webinar topics will provide learners with hands-on advice on topics such as securing funding and maximising impact of translational projects, principles of innovation management, and evaluating the translational potential of a research project. Further webinars will focus on personalised medicine and multi-omics research.
More information on EATRIS-Plus project on the project website.
Target audiences: senior scientists involved in vaccine development, both from academia and industry
Training scientists in vaccine research and development is crucial in order to sustain Europe’s excellence in this field. The TRANSVAC2 Consortium has set up a programme of 14 training modules at leading European centres that can be combined to create customised international courses on vaccine R&D. Participants can select topics as needed in their field of vaccine development, and the timelines of the various modules will be harmonised in a way that allows a logical continuation from one topic to the other.
EATRIS is the organizer of the M14 “Regulatory aspects of vaccine development”, which first edition will take place on June 7-8, 2021 online.
More information on TRANSVAC2 Training can be found on the project training website.
X-omics online workshop series
In June 2020, X-omics organized the first online workshop series. Different aspects of challenges and solutions related to multi-omics data integration were addressed in four workshops.
Master’s degree in Translational Biomedical Research
The Master in Translational Biomedical Research is an official master’s degree, led by Vall d’Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), that aims to generate excellent biomedical researchers with the necessary combination of scientific and medical knowledge, and skills to contribute successfully to the future of translational medical research. Further information and applications on the Master’s website.
I2TRON Doctoral Training Unit
i2TRON (Integrating immune strategies for Translational Research in Oncology and Neurology), is a multidisciplinary doctoral training program within the biomedical research community in Luxembourg. To address the current need for an interactive and interdisciplinary research culture and to implement overarching and integrative translational research concepts, it recruits PhD students with either a life sciences or medicine background. It brings together PhD and MD-PhD students of the Luxembourg Institute of Health, the University of Luxembourg, the Laboratoire national de santé and the Centre Hospitalier de Luxembourg. Its overarching goal is to develop the ability of doctoral candidates to successfully translate fundamental research findings into innovative pre-clinical and clinical applications, thereby shaping the next generation of translational scientists and developing advanced precision medicine and care. The focus of the research program is chronic inflammation, immune-oncology and neuroimmunology. The translational objectives are furthermore reflected in the i2TRON training program.
i2TRON is funded over a period of 6.5 years by the Luxembourg National Research Fund (FNR) through the competitive PRIDE program. Open PhD positions can be found here.
The University of Luxembourg (UL) introduced the AI4Health lecture series in early 2020 with a collection of lectures in the interdisciplinary field of Artificial Intelligence (AI) and Health. Due to its popularity, the series will continue in 2021 with new presentations. This year’s selection of topics will also include a special focus on COVID-19 to reflect current research efforts from different perspectives (humanities, social sciences, information & communication technologies) to highlight the translational nature of research.
The overall goal of the webinar series is to strengthen the relationship between computer science (especially AI and Human-Computer Interaction) and health, as this is one of the university’s top priorities. This working relationship is reflected in the fact that the organisation of the webinars is a joint event between the Department of Computer Science (DCS), the Department of Life Science and Medicine (DLSM) and the Luxembourg Centre for Systems Biomedicine (LCSB).